#1 Clinical Trials Search in Europe

Find a Clinical Trial

Search Trials by Disease

Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
Rare Diseases Treatments

Search Trials by Disease

Familial hypertriglyceridaemia Leiomyosarcoma recurrent Hypergammaglobulinaemia benign monoclonal Epstein-Barr virus associated lymphoproliferative disorder Chronic lymphocytic leukaemia recurrent Laryngeal squamous cell carcinoma Autoimmune demyelinating disease X-linked lymphoproliferative syndrome Palmar-plantar erythrodysaesthesia syndrome Uveal melanoma Primary immunodeficiency syndrome Encephalopathy neonatal Hypoxic-ischaemic encephalopathy Primitive neuroectodermal tumour Isodicentric chromosome 15 syndrome More trials…
Learn about Rare Diseases

Soft tissue sarcoma – Diagnostics Pemphigus – Trials in Disease Mantle cell lymphoma stage III Angiosarcoma metastatic – Trials in Disease Haemolytic uraemic syndrome Idiopathic pulmonary fibrosis – Trials in Disease Langerhans’ cell histiocytosis – Diagnostics Langerhans’ cell histiocytosis – Trials in Disease Leiomyosarcoma recurrent – Trials in Disease Behcet’s syndrome – Trials in Disease More diseases
Vaccine Clinical Trials
Pediatric Clinical Trials
Resources for Patients

Browse Innovative Treatments

Antithrombin Iii Human Atropine Sulfate Monohydrate Cefaclor PAPAVERINE HYDROCHLORIDE Vb10.16 Abc-35B-116 Romidepsin Varegacestat Lactulose Rbl035.2 HALOBETASOL PROPIONATE Certolizumab Pegol Romiplostim Carbamazepine Carbidopa Oleclumab ANX007 Sufentanil Citrate Moxifloxacin Duloxetine More therapies…

Learn about Your Condition

Lymphocytic lymphoma Strongyloidiasis Spermatocele Pericarditis Urethral stenosis Septic shock Relapsing multiple sclerosis Head and neck cancer Cervix carcinoma stage II Periodontitis Infertility Aplasia pure red cell Cleft lip and palate Incisional hernia Hernia repair More diseases
Healthy Volunteers
Patient Guide
Our Partners
About Us
Contact us
Region

🇪🇺 Europe
🇦🇹 Austria
🇭🇷 Croatia
🇨🇿 Czech Republic
🇩🇰 Denmark
🇪🇪 Estonia
🇫🇮 Finland
🇫🇷 France
🇩🇪 Germany
🇮🇸 Iceland
🇮🇹 Italy
🇱🇻 Latvia
🇱🇹 Lithuania
🇳🇱 Netherlands
🇳🇴 Norway
🇵🇱 Poland
🇵🇹 Portugal
🇷🇴 Romania
🇸🇰 Slovakia
🇸🇮 Slovenia
🇪🇸 Spain
🇸🇪 Sweden

Toxic epidermal necrolysis

Treatment with Mesenchymal Stromal Cells for Adults with Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis (SJS-TEN) Affecting More Than 10% of Body Surface

Recruiting

1 1 1
Investigated Drugs:
- Allogeneic Adipose-Derived Mesenchymal Stromal Cells, Ex-Vivo Expanded
Study on Filgrastim for Patients with Severe Bullous Drug Eruptions: Lyell and Stevens-Johnson Syndromes

Recruiting

4 1 1
Investigated Diseases:
- Stevens-Johnson syndrome
- Toxic epidermal necrolysis
Investigated Drugs:
- Glucose Monohydrate
- Filgrastim
Study of Tildrakizumab for Eye Problems in Patients with Lyell Syndrome

Not yet recruiting

2 1 1 1
Investigated Diseases:
- Toxic epidermal necrolysis
Investigated Drugs:
- Tildrakizumab

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

Toxic epidermal necrolysis

Treatment with Mesenchymal Stromal Cells for Adults with Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis (SJS-TEN) Affecting More Than 10% of Body Surface

Study on Filgrastim for Patients with Severe Bullous Drug Eruptions: Lyell and Stevens-Johnson Syndromes

Study of Tildrakizumab for Eye Problems in Patients with Lyell Syndrome

Investigational Drugs in This Location

Medical Conditions Being Studied in This Location

We use cookies